Title | Type | SJR | H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | %Female (2015) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Cancer | journal | 25.056 Q1 | 505 | 124 | 497 | 8643 | 8990 | 214 | 15.62 | 69.70 | 34.98 | |
2 | Journal of the National Cancer Institute | journal | 6.498 Q1 | 387 | 350 | 1034 | 8978 | 6419 | 517 | 6.25 | 25.65 | 43.30 | |
3 | Leukemia | journal | 5.189 Q1 | 219 | 326 | 1119 | 12318 | 8096 | 672 | 7.47 | 37.79 | 39.25 | |
4 | Oncogene | journal | 4.091 Q1 | 370 | 524 | 1630 | 29009 | 12531 | 1615 | 7.51 | 55.36 | 38.97 | |
5 | Neuro-Oncology | journal | 3.246 Q1 | 163 | 209 | 581 | 8141 | 3874 | 504 | 6.25 | 38.95 | 34.35 | |
6 | European Journal of Cancer | journal | 3.177 Q1 | 245 | 307 | 1176 | 10127 | 7703 | 1099 | 6.55 | 32.99 | 39.02 | |
7 | Breast Cancer Research | journal | 2.994 Q1 | 175 | 144 | 579 | 7174 | 3178 | 532 | 5.20 | 49.82 | 53.72 | |
8 | British Journal of Cancer | journal | 2.945 Q1 | 272 | 501 | 2032 | 18098 | 11825 | 1880 | 5.74 | 36.12 | 39.31 | |
9 | Cell Death and Disease | journal | 2.501 Q1 | 164 | 408 | 1270 | 19722 | 7310 | 1234 | 5.67 | 48.34 | 42.82 | |
10 | Carcinogenesis | journal | 2.439 Q1 | 223 | 186 | 982 | 11468 | 5545 | 971 | 5.30 | 61.66 | 40.15 | |
11 | Molecular Cancer | journal | 2.406 Q1 | 196 | 204 | 514 | 11037 | 3177 | 512 | 6.33 | 54.10 | 37.16 | |
12 | Journal of Hematology and Oncology | journal | 2.331 Q1 | 144 | 127 | 260 | 6097 | 1676 | 260 | 6.84 | 48.01 | 43.21 | |
13 | Advances in Biological Regulation | journal | 2.267 Q1 | 69 | 31 | 112 | 2650 | 484 | 103 | 5.51 | 85.48 | 39.22 | |
14 | Endocrine-Related Cancer | journal | 2.142 Q1 | 146 | 127 | 363 | 8647 | 1791 | 328 | 4.81 | 68.09 | 45.38 | |
15 | Journal for ImmunoTherapy of Cancer | journal | 1.929 Q1 | 117 | 83 | 63 | 2067 | 318 | 60 | 5.05 | 24.90 | 36.31 | |
16 | Oral Oncology | journal | 1.776 Q2 | 137 | 195 | 663 | 7257 | 2462 | 552 | 3.74 | 37.22 | 35.28 | |
17 | Prostate Cancer and Prostatic Diseases | journal | 1.693 Q2 | 78 | 58 | 173 | 2174 | 659 | 171 | 4.10 | 37.48 | 24.11 | |
18 | Epigenomics | journal | 1.678 Q2 | 77 | 114 | 215 | 8346 | 724 | 172 | 2.97 | 73.21 | 44.70 | |
19 | BMC Cancer | journal | 1.652 Q2 | 160 | 1021 | 2224 | 41703 | 8910 | 2218 | 3.70 | 40.85 | 40.72 | |
20 | Journal of Experimental and Clinical Cancer Research | journal | 1.639 Q2 | 120 | 154 | 312 | 6686 | 1548 | 312 | 4.90 | 43.42 | 41.71 | |
21 | Cancer Medicine | journal | 1.479 Q2 | 84 | 194 | 260 | 7550 | 903 | 257 | 3.41 | 38.92 | 35.47 | |
22 | Leukemia and Lymphoma | journal | 1.185 Q2 | 102 | 617 | 1522 | 17453 | 2861 | 912 | 1.90 | 28.29 | 42.01 | |
23 | Leukemia Research | journal | 1.049 Q2 | 96 | 226 | 903 | 7467 | 2079 | 711 | 2.56 | 33.04 | 45.55 | |
24 | Cancer Cell International | journal | 1.016 Q3 | 80 | 114 | 310 | 5044 | 957 | 308 | 3.25 | 44.25 | 40.63 | |
25 | Cancer Gene Therapy | journal | 1.014 Q3 | 99 | 74 | 263 | 3234 | 764 | 259 | 2.67 | 43.70 | 35.03 | |
26 | Infectious Agents and Cancer | journal | 0.992 Q3 | 47 | 49 | 130 | 1639 | 310 | 126 | 1.97 | 33.45 | 47.99 | |
27 | Experimental Hematology and Oncology | journal | 0.971 Q3 | 42 | 34 | 44 | 1380 | 113 | 42 | 2.51 | 40.59 | 44.95 | |
28 | Future Oncology | journal | 0.964 Q3 | 90 | 375 | 645 | 16831 | 1480 | 604 | 2.08 | 44.88 | 39.36 | |
29 | International Journal of Hyperthermia | journal | 0.947 Q3 | 98 | 100 | 247 | 5069 | 931 | 243 | 4.17 | 50.69 | 28.13 | |
30 | Japanese Journal of Clinical Oncology | journal | 0.870 Q3 | 95 | 204 | 647 | 5084 | 1404 | 574 | 2.11 | 24.92 | 19.51 | |
31 | Journal of Oral Pathology and Medicine | journal | 0.809 Q3 | 95 | 117 | 348 | 4646 | 793 | 342 | 1.97 | 39.71 | 42.50 | |
32 | Hematological Oncology | journal | 0.794 Q3 | 54 | 62 | 129 | 1620 | 268 | 112 | 2.24 | 26.13 | 39.08 | |
33 | ecancermedicalscience | journal | 0.430 Q3 | 47 | 110 | 248 | 4360 | 298 | 248 | 1.26 | 39.64 | 44.18 | |
34 | Molecular Therapy - Oncolytics | journal | 0.272 Q4 | 42 | 22 | 6 | 1480 | 4 | 5 | 0.67 | 67.27 | 34.53 | |
35 | European Journal of Cancer, Supplement | journal | 0.221 Q4 | 29 | 9 | 125 | 4 | 46 | 109 | 0.53 | 0.44 | 57.89 | |
36 | Cancer Treatment and Research Communications | journal | 0.113 Q4 | 23 | 52 | 13 | 1357 | 4 | 13 | 0.31 | 26.10 | 29.45 | |
37 | Cancer Communications | journal | 79 | 70 | 260 | 2589 | 741 | 240 | 2.98 | 36.99 | 41.07 | ||
38 | Cell Death Discovery | journal | 58 | 62 | 0 | 2843 | 0 | 0 | 0.00 | 45.85 | 38.24 | ||
39 | Molecular and Cellular Oncology | journal | 37 | 151 | 78 | 4346 | 20 | 71 | 0.26 | 28.78 | 39.94 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®